Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 25Unknown 11Recruiting 5Terminated 3Not yet recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 5Rectal Neoplasms 2Colonic Neoplasms 2Pancreatic Neoplasms 1Neuroendocrine Tumors 1Metastatic Colorectal Adenocarcinoma 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoma, Hepatocellular 1Advanced Rectal Cancer 1

Interventions

Capecitabine 13Fluorouracil 12Oxaliplatin 9Nivolumab 9Radiotherapy 8Leucovorin 8Cetuximab 8Magnetic Resonance Spectroscopy 6Irinotecan 5pembrolizumab 4encorafenib 4Surgical Procedures, Operative 4Sigmoidoscopy 4Radiotherapy, Intensity-Modulated 4Surveys and Questionnaires 3Standard of Care 3Specimen Handling 3Biopsy 3Bevacizumab 3dostarlimab 2dehydroftorafur 2atezolizumab 2XELOX 2X-Rays 2Observation 2Magnetic Resonance Imaging 2Immunoglobulin G 2Folfox protocol 2Drug Therapy 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Rectal Neoplasms × Folfox protocol × Clear all
NCT03548961 2026-05-22

Organ Preservation in Early Rectal Cancer Patients

Fox Chase Cancer Center

Phase 2 Active not recruiting
19 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05108428 2026-04-01

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡